151 related articles for article (PubMed ID: 350389)
1. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma.
Presant CA; Ratkin G; Klahr C
Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389
[No Abstract] [Full Text] [Related]
2. Phase II trial: mitomycin c and methotrexate combination therapy for advanced colorectal carcinoma.
Budman DR; Schulman P; Vinciguerra V; Degnan T
Cancer Treat Rep; 1981; 65(5-6):535. PubMed ID: 7237477
[No Abstract] [Full Text] [Related]
3. Phase II trial of a combination of cyclosphamide, vincristine, and methotrexate in advanced colorectal carcinoma.
Taylor SG; Desai SA; DeWys WD
Cancer Treat Rep; 1978 Aug; 62(8):1203-5. PubMed ID: 356978
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
[TBL] [Abstract][Full Text] [Related]
5. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil.
Kessinger MA; Foley JF; Lemon HM
Cancer Clin Trials; 1979; 2(4):317-9. PubMed ID: 394867
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer.
Buroker T; Wojtaszak B; Dindogru A; DeMattia M; Baker L; Groth C; Vaitkevicius VK
Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398
[TBL] [Abstract][Full Text] [Related]
7. 5-FU, methotrexate, and mitomycin in advanced colorectal adenocarcinoma: a phase II study.
Biran H; Sulkes A; Biran S
Cancer Treat Rep; 1981; 65(9-10):924-5. PubMed ID: 7273031
[No Abstract] [Full Text] [Related]
8. Mitomycin and methotrexate: negative experience in untreated colorectal carcinoma.
Wernz JC; Kao AK; Muggia FM; Asbury RF
Cancer Treat Rep; 1985 Feb; 69(2):223-4. PubMed ID: 3918793
[No Abstract] [Full Text] [Related]
9. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
Presant CA; Ratkin G; Klahr C
Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
[No Abstract] [Full Text] [Related]
10. Phase II trial of oral methotrexate and dipyridamole in colorectal carcinoma.
Wadler S; Subar M; Green MD; Wiernik PH; Muggia FM
Cancer Treat Rep; 1987 Sep; 71(9):821-4. PubMed ID: 3621214
[TBL] [Abstract][Full Text] [Related]
11. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
Greco FA; Richardson RL; Shulman SF; Oldham RK
Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
[No Abstract] [Full Text] [Related]
12. Phase II study of cyclophosphamide and cytarabine in the treatment of metastatic adenocarcinoma of the colon and rectum.
Denefrio JM; Kaplan RS; Eisenberger MA; Lessner HE
Cancer Treat Rep; 1981; 65(1-2):163-4. PubMed ID: 7226166
[No Abstract] [Full Text] [Related]
13. Phase II trial of maytansine in patients with advanced colorectal carcinoma.
O'Connell MJ; Shani A; Rubin J; Moertel CG
Cancer Treat Rep; 1978 Aug; 62(8):1237-8. PubMed ID: 356981
[No Abstract] [Full Text] [Related]
14. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
Carroll DS; Kemeny NE; Gralla RJ
Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
[No Abstract] [Full Text] [Related]
15. A phase 2 study of intermittent high-dose cyclophosphamide therapy of advanced gastrointestinal cancer.
Schutt AJ; Hahn RG; Reitemeier RJ; Moertel CG
Cancer Res; 1973 Oct; 33(10):2218-20. PubMed ID: 4741927
[No Abstract] [Full Text] [Related]
16. Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.
O'Connell MJ; Moertel CG; Rubin J; Schutt AJ; Creagan ET
Cancer Treat Rep; 1980; 64(2-3):311-3. PubMed ID: 7190870
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer.
Cantrell JE; Brunet R; Lagarde C; Schein PS; Smith FP
Cancer Treat Rep; 1982 Jul; 66(7):1563-5. PubMed ID: 7093972
[TBL] [Abstract][Full Text] [Related]
18. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine].
Roth A; Kolarić K
Lijec Vjesn; 1983 Jun; 105(6):244-6. PubMed ID: 6633141
[No Abstract] [Full Text] [Related]
19. Chemotherapy in alimentary tract malignomas.
Queisser W; Heim ME
Hepatogastroenterology; 1981 Oct; 28(5):276-83. PubMed ID: 6212524
[No Abstract] [Full Text] [Related]
20. Chemotherapy for colorectal cancer with a combination of 5-fluorouracil, mitomycin C, adriamycin, and cytosine arabinoside: a pilot study.
Davis S; Park YK
Cancer Treat Rep; 1978 Oct; 62(10):1557-9. PubMed ID: 709556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
